首页 工具
登录
购物车

搜索结果

Search Results for " raf kinases "
Targets Recommended: Raf

53

抑制剂 & 化合物

2

化合物库

2

重组蛋白

如果没找到您满意的产品或者您对产品有其他要求,可以联系我们专业顾问为您提供针对性的合理建议。     QQ咨询       网站留言咨询

提交您的定制咨询

点击图片重新获取验证码
Cat. No. Product Name
L1610 FDA 上市激酶抑制剂库

263 compounds
263种靶向激酶的上市药物集合,用于特定靶向激酶,可用于高通量筛选和高内涵筛选;
L1600 激酶抑制剂库

2720 compounds
2720 种激酶抑制剂/调节剂的独特集合,用于特定靶向激酶,可用于高通量筛选和高内涵筛选;

化合物库

FDA 上市激酶抑制剂库
Cat.No: L1610
Compounds: 263
激酶抑制剂库
Cat.No: L1600
Compounds: 2720
Cat. No. Product Name Target Signaling Pathways
T10599 BRAF inhibitor

Raf MAPK
BRAF inhibitor 是B-Raf 抑制剂。
T3711 RAF709

Raf MAPK
RAF709 是RAF 抑制剂,抑制BRAF 和CRAF,IC50分别为 0.4 和 0.5 nM,具有抗肿瘤活性。
T1845 B-Raf IN 1

Raf MAPK
B-Raf IN 1 是选择性B-Raf 抑制剂, IC50为 24 nM。
T2295 SB-590885

Raf MAPK
SB590885 是一种 B-Raf 抑制剂,Ki 值为 0.16 nM,对其选择性是对 c-Raf 的 11 倍多。
T2473 PLX-4720

PLX4720

Raf MAPK
PLX-4720 是一种有效且选择性的 B-Raf (V600E) 抑制剂,IC50为 13 nM,与 c-Raf-1(Y340D 和 Y341D 突变)同样有效。
T6318 AZ 628

Apoptosis; Raf Apoptosis; MAPK
AZ 628 是一种泛Raf 激酶抑制剂,抑制B-Raf、B-RafV600E 和c-Raf-1,IC50分别为 105、34和 29 nM。
T4194 Raf inhibitor 2

CID-25014542,CID 25014542,CID25014542

Raf MAPK
Raf inhibitor 2 (CID 25014542) 是新型 Raf 激酶抑制剂,IC50小于 1.0 μM,可用于癌症研究。
T2074 Raf inhibitor 1

B-Raf inhibitor 1

Raf MAPK
Raf inhibitor 1 (B-Raf inhibitor 1)是Raf 激酶抑制剂,对B-RafWT、B-RafV600E 和 C-Raf 的Ki 分别为 1、1 和 0.3 nM。
T4133 CCT196969

Raf; Src Angiogenesis; MAPK; Tyrosine Kinase/Adaptors
CCT196969 是泛-Raf 抑制剂,抑制B-Raf、BRafV600E 和CRAF,IC50分别为 0.1、0.04、和 0.01 μM。
T1953 L-779450

L 779450

Raf; Autophagy Autophagy; MAPK
L-779450 是一种有效的 ATP 竞争性 Raf 激酶抑制剂,IC50为 10 nM,Kd 为 2.4 nM。
T1886 TAK-632

Raf; FGFR; PDGFR; Aurora Kinase Angiogenesis; Cell Cycle/Checkpoint; Chromatin/Epigenetic; MAPK; Tyrosine Kinase/Adaptors
TAK632 是一种有效的pan-RAF 抑制剂,对CRAF、BRAFV600E 和BRAFWT 的IC50分别为 1.4、2.4 和 8.3 nM。
T6296 RAF265

CHIR-265

Apoptosis; Raf; VEGFR; Autophagy Angiogenesis; Apoptosis; Autophagy; MAPK; Tyrosine Kinase/Adaptors
RAF265 (CHIR-265) 是一种 RAF/VEGFR2抑制剂。
T9693 TBAP-001

Raf MAPK
TBAP-001是RAF 激酶的泛抑制剂,IC50为 62 nM。
TQ0048 BI-882370

Raf MAPK
BI-882370 是高选择性的RAF 激酶抑制剂,其结合位于 BRAF 激酶的 DFG-out 无活性构象处 (ATP 结合位点)。 它抑制 SRC 家族激酶,也抑制 BRAFV600E-mutant、WT BRAF 和 CRAF 激酶,IC50值分别为 0.4、0.8 和 0.6 nM。
T24437 MCP110

MCP-110,MCP 110

Raf; Ras GPCR/G Protein; MAPK
MCP110 是 Ras 与 Raf-1 相互作用的抑制剂,可用于治疗人类肿瘤的研究。
T4167 Raf inhibitor 1 dihydrochloride

B-Raf inhibitor 1 dihydrochloride

Raf MAPK
Raf inhibitor 1 dihydrochloride (B-Raf inhibitor 1 dihydrochloride) 是 Raf 激酶抑制剂,对 B-RafWT、B-RafV600E 和 C-Raf 的Ki 分别为 1、1 和 0.3 nM。
T1851 ZM 336372

Zinc00581684

Apoptosis; Raf Apoptosis; MAPK
ZM 336372 是一种选择性蛋白激酶 c-Raf 抑制剂。
T15794 LUT014

Raf MAPK
LUT014 是B-Raf 抑制剂,IC50值为 11.7 nM,用于减少与 EGFR 抑制剂相关限制剂量的痤疮样病变研究。
T5172 AZ304

c-Fms; Raf; p38 MAPK; Autophagy Autophagy; MAPK; Tyrosine Kinase/Adaptors
AZ304 是一种 ATP 竞争性双 BRAF 激酶抑制剂,有效抑制 BRAF (WT)、BRAF (V600E) 和野生型 CRAF,IC50值分别为79、38和68 nM。具有抗肿瘤活性。它对 p38 和 CSF1R 也有抑制作用,IC50值分别为 6 nM 和 35 nM。
T1903 Dabrafenib

GSK2118436A,GSK2118436,达拉非尼

Raf MAPK
Dabrafenib (GSK2118436A) 是一种 Raf 抑制剂,抑制 C-Raf 和 B-RafV600E (IC50=5/0.6 nM),具有 ATP 竞争性。Dabrafenib 具有抗肿瘤活性,可用于治疗 B-RafV600E 突变的黑色素瘤。
T11224 Rineterkib

ERK-IN-1

ERK; Raf MAPK
Rineterkib (ERK-IN-1) 是口服有效的RAF 和ERK1/2的抑制剂,与 KRAS-突变型非小细胞肺癌、BRAF-突变型非小细胞肺癌、KRAS-突变型胰腺癌、KRAS -突变型结肠癌和 KRAS-突变型卵巢癌尤为相关。
T5634 Belvarafenib

Raf MAPK
Belvarafenib 是一种有效的泛 RAF 抑制剂,具有抗肿瘤活性,对 B-RAF、B-RAFv600E 和 C-RAF 的 IC50值分别为 56、7 和 5 nM。
T6487 Encorafenib

LGX818

Raf MAPK
Encorafenib (LGX818) 是一种可口服的突变型 BRaf V600E 抑制剂,IC50为 0.3 nM,具有潜在的抗肿瘤活性。
T6949 PLX7904

PB04

Raf MAPK
PLX7904 (PB04) 是一种有效且选择性的悖论破坏剂 RAF 抑制剂,可抑制突变 BRAF 黑色素瘤细胞中 ERK1/2 的激活。在表达突变体 RAS 的细胞中,对 BRAFV600E 的IC50值约为 5 nM。
T11898 LXH254

Raf MAPK
LXH254 是B/C RAF 抑制剂。
T6882 LY3009120

DP-4978

Raf; Autophagy Autophagy; MAPK
LY3009120 (DP-4978) 是一种泛RAF 抑制剂,其抑制BRAFV600E、BRAFWT 和CRAFWT 的IC50分别为 5.8、9.1和15 nM。
T4301 AD80

Raf; c-RET; Src; S6 Kinase Angiogenesis; Apoptosis; MAPK; PI3K/Akt/mTOR signaling; Tyrosine Kinase/Adaptors
AD80 是多激酶抑制剂,可抑制 RET、RAF、SRC 和 S6K,并大大降低 mTOR 活性。
T22272 Lifirafenib

BGB-283,Beigene-283

EGFR; Raf Angiogenesis; JAK/STAT signaling; MAPK; Tyrosine Kinase/Adaptors
Lifirafenib (Beigene-283) 是新型高效的Raf 激酶和EGFR 抑制剂,对重组BRafV600E 和EGFR 的IC50值分别为 23 和 29 nM。
T6320 GDC-0879

GDC 0879,AR-00341677,GDC0879

Raf MAPK
GDC-0879 (AR-00341677) 是一种选择性B-Raf 抑制剂,IC50为 0.13 nM。
T8745 PROTAC BRAF-V600E degrader-1

Compound 23

Raf; PROTACs MAPK; PROTAC
PROTAC BRAF-V600E degrader-1 (Compound 23) 选择性地诱导 BRAF-V600E 的降解,而不是野生型 BRAF
T41003 KG5

Raf; FLT; PDGFR; c-Kit Angiogenesis; MAPK; Tyrosine Kinase/Adaptors
KG5 是 PDGFRβ 和 B-Raf 的双重变构抑制剂,对 PDGFRβ 和 PDGFRα 的 Kd 分别为 520 nM 和 300 nM。 KG5 抑制 FLT3、KIT 和 c-Raf,具有抗癌和抗血管生成活性。
T2070 Agerafenib

RXDX-105,CEP 32496,CEP-32496,CEP32496

Raf; c-RET; Bcr-Abl; PDGFR; Src; c-Kit Angiogenesis; Apoptosis; Cytoskeletal Signaling; MAPK; Tyrosine Kinase/Adaptors
Agerafenib (CEP32496) 是口服高效的 BRAFV600E 抑制剂,Kd 为 14 nM。
T6277 Doramapimod

BIRB 796,达马莫德,度马莫德

Raf; p38 MAPK; Autophagy Autophagy; MAPK
Doramapimod (BIRB 796) 是一种具有口服活性的p38 MAPK 抑制剂,Kd 值为0.1nM。它也抑制B-Raf 和 Abl,IC50分别为 83 nM 和 14.6 μM。
T6895 TAK-580

MLN2480,BIIB-024

Raf MAPK
TAK-580 (MLN2480) 是一种可口服的选择性Raf 广谱抑制剂。
T8402 Regorafenib Hydrochloride

瑞戈非尼盐酸盐,BAY73-4506 hydrochloride

Raf; VEGFR; c-RET; PDGFR; Autophagy Angiogenesis; Apoptosis; Autophagy; MAPK; Tyrosine Kinase/Adaptors
Regorafenib Hydrochloride (BAY73-4506 hydrochloride) 是一种新型口服多激酶抑制剂,可抑制血管生成、基质和致癌受体酪氨酸激酶,具有强大的临床前抗肿瘤活性。它靶向作用于 VEGFR1/2/3、PDGFRβ、Kit、RET 和 Raf-1,IC50值分别为 13/4.2/46、22、7、1.5 和 2.5 nM。
T22436 Takeda-6d

VEGFR Angiogenesis; Tyrosine Kinase/Adaptors
Takeda-6d 是一种新型、有效的 DFG-out RAF/血管内皮生长因子受体 2 (VEGFR2) 抑制剂,IC50 分别为 7.0 nM 和 2.2 nM。
T6971 Ro 5126766

CH5126766,Avutometinib,VS-6766,RO5126766

Raf; MEK MAPK
Ro 5126766 (CH5126766) 是双重MEK/RAF 抑制剂,抑制BRAFV600E、CRAF、MEK 和 BRAF,IC50分别为 8.2、56、160 和 190 nM。
T2382 Vemurafenib

RO5185426,RG7204,维罗非尼,PLX4032

Raf; MAPK; ACK; Src; Autophagy Angiogenesis; Autophagy; MAPK; Tyrosine Kinase/Adaptors
Vemurafenib (RG7204) 是一种 B-RAF 抑制剂,可以抑制 RAFV600E 和 c-RAF-1 (IC50=31/48 nM),具有选择性和有效性。Vemurafenib 具有抗肿瘤活性,用于 BRAF V600E 突变阳性的黑色素瘤治疗。
T1792L Regorafenib monohydrate

Raf; VEGFR; c-RET; PDGFR; c-Kit; Autophagy Angiogenesis; Apoptosis; Autophagy; MAPK; Tyrosine Kinase/Adaptors
Regorafenib monohydrate 是一种新型口服多激酶抑制剂,对VEGFR1/2/3、PDGFRβ、Kit、RET 和Raf-1的IC50分别为 13、4.2、46、22、7、1.5 和 2.5 nM。
T0093L Sorafenib

索拉非尼,Bay 43-9006

Apoptosis; Raf; VEGFR; FLT; Ferroptosis; PDGFR; c-Kit; Autophagy Angiogenesis; Apoptosis; Autophagy; MAPK; Tyrosine Kinase/Adaptors
Sorafenib (Bay 43-9006) 是一种多激酶抑制剂,抑制 Raf-1、B-Raf、VEGFR2、VEGFR3、VEGFR4、PDGFRβ、FLT3、c-Kit 等 (IC50=6/22/90/15/20/20/57/58 nM),具有口服活性。Sorafenib 具有抗肿瘤活性,可以诱导细胞自噬和凋亡,也可以激动铁死亡。
T8474 Dabrafenib Mesylate

达帕菲尼甲磺酸盐,甲磺酸达拉非尼,GSK 2118436B,GSK2118436 Mesylate

Raf MAPK
Dabrafenib Mesylate (GSK2118436 Mesylate) 是一种ATP 竞争型Raf 抑制剂,抑制C-Raf 和B-RafV600E 的IC50分别为 5 和 0.6 nM。
T6525 GW 5074

GW5074,3-(3,5-二溴-4-羟基苯亚甲基)-5-碘-1,3-二氢吲哚-2-酮,Raf1 Kinase Inhibitor I

Apoptosis; Raf Apoptosis; MAPK
GW 5074 (Raf1 Kinase Inhibitor I) 是一种有效且特异性的 c-Raf 抑制剂,IC50值为 9 nM。 它对 JNK1/2/3、MEK1、MKK6/7、CDK1/2、c-Src、p38 MAP、VEGFR2 或 c-Fms 的活性没有影响。
T0093 Sorafenib tosylate

甲苯磺酸索拉非尼,Bay 43-9006

Apoptosis; Raf; VEGFR; FLT; Ferroptosis; PDGFR; c-Kit; Autophagy Angiogenesis; Apoptosis; Autophagy; MAPK; Tyrosine Kinase/Adaptors
Sorafenib tosylate (Bay 43-9006) 是一种多激酶抑制剂,抑制 Raf-1、B-Raf、VEGFR2、VEGFR3、VEGFR4、PDGFRβ、FLT3、c-Kit 等 (IC50=6/22/90/15/20/20/57/58 nM),具有口服活性。Sorafenib 具有抗肿瘤活性,可以诱导细胞自噬和凋亡,也可以激动铁死亡。
T1792 Regorafenib

BAY 73-4506,瑞戈非尼,Fluoro-Sorafenib,瑞格非尼

Raf; VEGFR; c-RET; PDGFR; c-Kit; Autophagy Angiogenesis; Apoptosis; Autophagy; MAPK; Tyrosine Kinase/Adaptors
Regorafenib (BAY 73-4506) 是一种多靶点受体酪氨酸激酶抑制剂,抑制 RET、C-RAF、VEGFR2、c-Kit、VEGFR1 和 PDGFRβ (IC50=1.5/2.5/4.2/7/13/22 nM),具有口服活性。Regorafenib 具有抗肿瘤和抗血管生成活性。
T38511 AWL-II-38.3

Ephrin Receptor Tyrosine Kinase/Adaptors
AWL-II-38.3 is a highly effective inhibitor of EphA3, a receptor for ephrin-A. It demonstrates potent kinase inhibitory activity against EphA3 and does not show significant cellular activity against Src-family kinases or b-raf [1] [2].
T68523 AMG-628, (S)-

Others Others
AMG-628, (S)-, is the S isomer of AMG-628 --- a potent, ATP-competitive inhibitor of Raf kinases. AMG-628 displays selectivity for Raf kinases and inhibits activation of tyrosine protein kinases such as VEGFR2, Lyn, Flt1 and Fms. AMG-628 has shown to inhibit growth, and induces cell cycle arrest and apoptosis in colon and melanoma cell lines with the B-RafV600E mutation.
T25350 DPQZ

Others Others
DPQZ is an anti-tubulin compound acting by inducing cell apoptosis in human oral cancer cells through Ras/Raf inhibition and MAP kinases activation.
T71736 AMG-628, (R)-

Others Others
AMG-628, (R)- is the R isomer of AMG-628 --- a potent, ATP-competitive inhibitor of Raf kinases. AMG-628 displays selectivity for Raf kinases and inhibits activation of tyrosine protein kinases such as VEGFR2, Lyn, Flt1 and Fms. AMG-628 has shown to inhibit growth, and induces cell cycle arrest and apoptosis in colon and melanoma cell lines with the B-RafV600E mutation.
T36681 Sorafenib N-oxide

Others Others
Sorafenib N-oxide is an active metabolite of sorafenib , an inhibitor of Raf-1, B-RAF, and receptor tyrosine kinases. Sorafenib N-oxide inhibits FLT3 that contains the internal tandem duplication mutation (FLT3-ITD; Kd = 70 nM) and inhibits proliferation of MV4-11 acute myeloid leukemia (AML) cells expressing FLT3-ITD (IC50 = 25.8 nM). It is selective for AML cell lines containing FLT3-ITD over lines containing wild-type FLT3 (IC50s = 3.9-13.3 μM). Sorafenib N-oxide is also a linear-mixed inhibi...
T28510 REDX05358

REDX 05358,REDX-05358

Others Others
REDX05358 is a highly selective and potent pan RAF inhibitor with a potential therapeutic for BRAF and RAS mutant tumors. REDX05358 has improved therapeutic potential and predicted safety profile. REDX05358 demonstrates subnanomolar binding affinity for B

化合物

BRAF inhibitor
Cat.No: T10599
Synonym:
Target: Raf
RAF709
Cat.No: T3711
Synonym:
Target: Raf
B-Raf IN 1
Cat.No: T1845
Synonym:
Target: Raf
SB-590885
Cat.No: T2295
Synonym:
Target: Raf
PLX-4720
Cat.No: T2473
Synonym: PLX4720
Target: Raf
AZ 628
Cat.No: T6318
Synonym:
Target: Apoptosis, Raf
Raf inhibitor 2
Cat.No: T4194
Synonym: CID-25014542,CID 25014542,CID25014542
Target: Raf
Raf inhibitor 1
Cat.No: T2074
Synonym: B-Raf inhibitor 1
Target: Raf
CCT196969
Cat.No: T4133
Synonym:
Target: Raf, Src
L-779450
Cat.No: T1953
Synonym: L 779450
Target: Raf, Autophagy
TAK-632
Cat.No: T1886
Synonym:
Target: Raf, FGFR, PDGFR, Aurora Kinase
RAF265
Cat.No: T6296
Synonym: CHIR-265
Target: Apoptosis, Raf, VEGFR, Autophagy
TBAP-001
Cat.No: T9693
Synonym:
Target: Raf
BI-882370
Cat.No: TQ0048
Synonym:
Target: Raf
MCP110
Cat.No: T24437
Synonym: MCP-110,MCP 110
Target: Raf, Ras
Raf inhibitor 1 dihydrochloride
Cat.No: T4167
Synonym: B-Raf inhibitor 1 dihydrochloride
Target: Raf
ZM 336372
Cat.No: T1851
Synonym: Zinc00581684
Target: Apoptosis, Raf
LUT014
Cat.No: T15794
Synonym:
Target: Raf
AZ304
Cat.No: T5172
Synonym:
Target: c-Fms, Raf, p38 MAPK, Autophagy
Dabrafenib
Cat.No: T1903
Synonym: GSK2118436A,GSK2118436,达拉非尼
Target: Raf
Rineterkib
Cat.No: T11224
Synonym: ERK-IN-1
Target: ERK, Raf
Belvarafenib
Cat.No: T5634
Synonym:
Target: Raf
Encorafenib
Cat.No: T6487
Synonym: LGX818
Target: Raf
PLX7904
Cat.No: T6949
Synonym: PB04
Target: Raf
LXH254
Cat.No: T11898
Synonym:
Target: Raf
LY3009120
Cat.No: T6882
Synonym: DP-4978
Target: Raf, Autophagy
AD80
Cat.No: T4301
Synonym:
Target: Raf, c-RET, Src, S6 Kinase
Lifirafenib
Cat.No: T22272
Synonym: BGB-283,Beigene-283
Target: EGFR, Raf
GDC-0879
Cat.No: T6320
Synonym: GDC 0879,AR-00341677,GDC0879
Target: Raf
PROTAC BRAF-V600E degrader-1
Cat.No: T8745
Synonym: Compound 23
Target: Raf, PROTACs
KG5
Cat.No: T41003
Synonym:
Target: Raf, FLT, PDGFR, c-Kit
Agerafenib
Cat.No: T2070
Synonym: RXDX-105,CEP 32496,CEP-32496,CEP32496
Target: Raf, c-RET, Bcr-Abl, PDGFR, Src, c-Kit
Doramapimod
Cat.No: T6277
Synonym: BIRB 796,达马莫德,度马莫德
Target: Raf, p38 MAPK, Autophagy
TAK-580
Cat.No: T6895
Synonym: MLN2480,BIIB-024
Target: Raf
Regorafenib Hydrochloride
Cat.No: T8402
Synonym: 瑞戈非尼盐酸盐,BAY73-4506 hydrochloride
Target: Raf, VEGFR, c-RET, PDGFR, Autophagy
Takeda-6d
Cat.No: T22436
Synonym:
Target: VEGFR
Ro 5126766
Cat.No: T6971
Synonym: CH5126766,Avutometinib,VS-6766,RO5126766
Target: Raf, MEK
Vemurafenib
Cat.No: T2382
Synonym: RO5185426,RG7204,维罗非尼,PLX4032
Target: Raf, MAPK, ACK, Src, Autophagy
Regorafenib monohydrate
Cat.No: T1792L
Synonym:
Target: Raf, VEGFR, c-RET, PDGFR, c-Kit, Autophagy
Sorafenib
Cat.No: T0093L
Synonym: 索拉非尼,Bay 43-9006
Target: Apoptosis, Raf, VEGFR, FLT, Ferroptosis, PDGFR, c-Kit, Autophagy
Dabrafenib Mesylate
Cat.No: T8474
Synonym: 达帕菲尼甲磺酸盐,甲磺酸达拉非尼,GSK 2118436B,GSK2118436 Mesylate
Target: Raf
GW 5074
Cat.No: T6525
Synonym: GW5074,3-(3,5-二溴-4-羟基苯亚甲基)-5-碘-1,3-二氢吲哚-2-酮,Raf1 Kinase Inhibitor I
Target: Apoptosis, Raf
Sorafenib tosylate
Cat.No: T0093
Synonym: 甲苯磺酸索拉非尼,Bay 43-9006
Target: Apoptosis, Raf, VEGFR, FLT, Ferroptosis, PDGFR, c-Kit, Autophagy
Regorafenib
Cat.No: T1792
Synonym: BAY 73-4506,瑞戈非尼,Fluoro-Sorafenib,瑞格非尼
Target: Raf, VEGFR, c-RET, PDGFR, c-Kit, Autophagy
AWL-II-38.3
Cat.No: T38511
Synonym:
Target: Ephrin Receptor
AMG-628, (S)-
Cat.No: T68523
Synonym:
Target: Others
DPQZ
Cat.No: T25350
Synonym:
Target: Others
AMG-628, (R)-
Cat.No: T71736
Synonym:
Target: Others
Sorafenib N-oxide
Cat.No: T36681
Synonym:
Target: Others
REDX05358
Cat.No: T28510
Synonym: REDX 05358,REDX-05358
Target: Others
Cat. No. Product Name Species Expression System
TMPY-05095 RAF1 Protein, Human, Recombinant (His & GST)

Raf-1 proto-oncogene, serine/threonine kinase,C...

Human Baculovirus Insect Cells
RAF1 gene is the cellular homolog of viral raf gene (v-raf). The encoded protein is a MAP kinase kinase kinase (MAP3K), which functions downstream of the Ras family of membrane associated GTPases to which it binds directly. Once activated, the cellular RAF1 protein can phosphorylate to activate the dual specificity protein kinases MEK1 and MEK2, which in turn phosphorylate to activate the serine/threonine specific protein kinases, ERK1 and ERK2. Activated ERKs are pleiotropic effectors of cell p...
TMPY-04411 YES1 Protein, Human, Recombinant (His & GST)

HsT441,c-yes,YES proto-oncogene 1, Src family tyrosine kinas...

Human Baculovirus Insect Cells
Proto-oncogene tyrosine-protein kinase Yes, also known as Proto-oncogene c-Yes, p61-Yes and YES1, is a cytoplasm protein that belongs to the protein kinase superfamily, Tyr protein kinase family and SRC subfamily. YES1 / c-Yes contains one protein kinase domain, one SH2 domain and one SH3 domain. It is thought that the subcellular distribution of Src-family tyrosine kinases, including c-Yes binding to the cellular membrane, is membranous and/or cytoplasmic. YES1 / c-Yes protein tyrosine kinase i...

重组蛋白

RAF1 Protein, Human, Recombinant (His & GST)
Cat.No: TMPY-05095
Species: Human
Expression System: Baculovirus Insect Cells
YES1 Protein, Human, Recombinant (His & GST)
Cat.No: TMPY-04411
Species: Human
Expression System: Baculovirus Insect Cells
共53条,每页50条 1 2
TargetMol Loading
联系我们
400-820-0310

上海市静安区江场三路238号8楼